Ovid Therapeutics Inc. Current Assets
Ovid Therapeutics Inc. (OVID) had Current Assets of $123.62 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $123.62M.
- 2026-03-31: Assets, Current $160.15M.
- 2025-12-31: Assets, Current $74.37M.
- 2025-09-30: Assets, Current $28.82M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $123.62M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $160.15M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $74.37M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $28.82M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $42.09M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $45.92M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $55.94M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $65.83M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $80.89M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $93.17M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $109.60M 10-K · filed 2025-03-11 | $109.60M 10-K · filed 2024-03-08 |
| 2023-09-30 | $91.71M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $102.17M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $119.52M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $131.38M 10-K · filed 2024-03-08 | |
| 2022-09-30 | $140.50M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $156.08M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $170.09M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $190.48M 10-K · filed 2023-03-13 | |
| 2021-09-30 | $205.06M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $215.87M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $236.66M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $74.84M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $90.35M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $44.11M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $60.74M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $79.81M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $39.15M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $53.61M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $62.82M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $44.27M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $55.25M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $65.19M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $75.69M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $88.59M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $96.87M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $107.31M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $46.54M 10-Q · filed 2017-06-13 | |
| 2016-12-31 | $52.41M 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |